Itabashi Michio
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Professor (Fixed Term) |
|
Language | English |
Title | Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer |
Conference | 2016 ACCO Annual Meeting |
Conference Type | International society and overseas society |
Presentation Type | Poster notice |
Lecture Type | General |
Publisher and common publisher | ◎MIURA Takuya, SUNAMI Eiji, KUSUMOTO Tetsuya, OTA Mitsuyoshi, YOSHIDA Kazuhiro, TOMITA Naohiro, MAEDA Atsuyuki, MOCHIZUKI Izumi, OKABE Michio, KUNIEDA Katsuyuki, YAMAUCHI Junichiro, ITABASHI Michio, KOTERA Kenjiro, TAKAHASHI Keiichi, BABA Hideo, Boku Narikazu, AIBA Keisuke, ISHIGURO Megumi, Morita Satoshi, SUGIHARA Kenichi, and ACTS-CC 02 Study Group |
Date | 2016/06/03 |
Venue (city and name of the country) |
Chicago |
Society abstract | Journal of Clinical Oncology 34(15),3622 2016 |